BEIJING, July 16, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading developer and provider of vaccines in China, announced today that it will hold its 2012 Annual Meeting of Shareholders on Wednesday, August 22, 2012 at 9:00 a.m. Beijing Time. The meeting will be held concurrently at No. 39 Shangdi Xi Road, Haidian District, Beijing, PRC and at No. 6 Temple Street, St. John's, Antigua. All shareholders of record as of July 5, 2012 will be eligible to vote and are invited to attend.
The primary agenda of the meeting is to approve the re-election of Weidong Yin, Yuk Lam Lo, Simon Anderson, Kenneth Lee and Meng Mei as the Company's directors until the next annual meeting of shareholders and or until their successors are duly elected; approve the audited consolidated financial statements of the Company for the financial year ended December 31, 2011 together with the Report of Independent Registered Public Accounting Firm thereon and the notes thereto; approve the appointment of Ernst & Young LLP as the independent auditor of the Company for the fiscal year ending December 31, 2012 and to authorize the directors of the Company to fix such independent auditor's remuneration; approve the Sinovac Biotech Ltd. 2012 Share Incentive Plan and the authorization for the issuance of 4,000,000 common shares under such plan; and approve the amendment to Section 7.5 of the Company's by-laws in order to lower the quorum of shareholders' meetings from 50%half to 33 1/3% one-third percent of common shares outstanding.
Sinovac's 2011 annual report and proxy statements, including the Notice of the 2012 Annual General Meeting, are available on the Company's website: http://www.sinovac.com.cn/en/?optionid=751.Shareholders of the Company may receive a hard copy of 20-F free of charge upon request. Such request can be made by sending an e-mail to firstname.lastname@example.org, along with complete contact details and a mailing address. About Sinovac
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV